what are the two glp 1 drugs GLP-1 Agonists: A Comprehensive Overview Evolution of GLP‐1 Receptor Agonists

[40] reported that liraglutide 3.0 mg over 24 weeks achieved modest BW loss of about 2.5% but substantial reduction in FBM, particularly in the android region

Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): A 56-week, double-blind, phase 3a, randomised trial

As Blyumin put it, they were given limited use authorizations to compound these drugs that otherwise they shouldnt be able to, because theyre on patent. Now, those shortages have ended, and compounding pharmacies no longer have a legal basis for producing identical copies of GLP-1s

Thorkildsen C, Neve S, Larsen BD, Meier E, Petersen JS

Subsequent large analyses did not confirm a significant increase in pancreatitis incidence due to GLP-1 RAs ( [64] ) ( [107] ), although a small elevation in risk cant be entirely ruled out (this is discussed under Safety)

The risk of gastroparesis has prompted surgeons to recommend stopping GLP-1 RAs before certain procedures